Gene · 22807
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics. | bioRxiv | 2023 | 37986917 | PubTator, text mining | PubMed |
| Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. | Nat Commun | 2023 | 37985656 | PubTator, text mining | PubMed |
| Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer. | Cell Discov | 2023 | 37968259 | PubTator, text mining | PubMed |
| Memory regulatory T cells in pregnancy. | Front Immunol | 2023 | 37954599 | PubTator, text mining | PubMed |
| Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer. | Mil Med Res | 2023 | 37941075 | PubTator, text mining | PubMed |
| Transcriptome profiling of regulatory T cells from children with transient hypogammaglobulinemia of infancy. | Clin Exp Immunol | 2023 | 37936298 | PubTator, text mining | PubMed |
| Natural Selection Signatures in the Hondo and Ryukyu Japanese Subpopulations. | Mol Biol Evol | 2023 | 37903429 | PubTator, text mining | PubMed |
| Unlocking the potential of Tregs: innovations in CAR technology. | Front Mol Biosci | 2023 | 37900916 | PubTator, text mining | PubMed |
| Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy. | J Hematol Oncol | 2023 | 37880715 | PubTator, text mining | PubMed |
| Negative impact of Interleukin-9 on synovial regulatory T cells in rheumatoid arthritis. | Clin Immunol | 2023 | 37879380 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. | EBioMedicine | 2023 | 37879219 | PubTator, text mining | PubMed |
| Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function. | JCI Insight | 2023 | 37874660 | PubTator, text mining | PubMed |
| High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases. | J Clin Invest | 2023 | 37874643 | PubTator, text mining | PubMed |
| Recent advances in understanding T cell activation and exhaustion during HBV infection. | Virol Sin | 2023 | 37866815 | PubTator, text mining | PubMed |
| Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients. | Cell Rep Med | 2023 | 37852175 | PubTator, text mining | PubMed |
| Regulatory T cells and cardiovascular diseases. | Chin Med J (Engl) | 2023 | 37840195 | PubTator, text mining | PubMed |
| Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37835465 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Cells in the Lung of a Patient with Chronic Hypersensitivity Pneumonitis Reveals Inflammatory Niche with Abundant CD39+ T Cells with Functional ATPase Phenotype: A Case Study. | Int J Mol Sci | 2023 | 37833889 | PubTator, text mining | PubMed |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. | Leukemia | 2023 | 37833543 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023. | Hum Vaccin Immunother | 2023 | 37814513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22807/papers?page=12